National Heart, Lung, and Blood Institute (NHLBI): Thrombosis trials

The registry lists 12 Thrombosis studies with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 3 2No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Platelet Volunteers, Longitudinal and Multi-omic StudyRecruitingNCT07137429
• Controls and Healthy Vasculature InitiativeRecruitingNCT05403151
• Clarification of Optimal Anticoagulation Through GeneticsCompletedNCT00839657Phase 3
• Transcranial Doppler (TCD) Ultrasound of Subjects Enrolled in BABY HUG - Ancillary to BABY HUGCompletedNCT00059293
• Mechanisms of Pro-Thrombosis in Diabetes Mellitus -- Ancillary to BARI 2DCompletedNCT00041405
• Genetic Architecture of Plasma T-PA and PAI-1CompletedNCT00007410
• Inflammation Markers Over Time in Cardiovascular DiseaseCompletedNCT00005692
• Oral Anticoagulant Therapy for Venous Thrombosis - SCOR in ThrombosisCompletedNCT00005684
• Lupus Cohort--Thrombotic Events and Coronary Artery DiseaseCompletedNCT00005436
• Novel Hemostatic Cardiac Risk Factors in FraminghamCompletedNCT00005356
• Mechanisms Underlying Psychosocial Associations With Ischemic Heart Disease (Kuopio)CompletedNCT00005260
• Postmenopausal Estrogen/Progestin Interventions (PEPI)CompletedNCT00000466Phase 3